Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?

Winston W. Tan, MD


December 21, 2021

Systemic disease treatments are used to prolong survival and improve quality of life. Single-agent sequential cytotoxic therapy is preferred in the setting of metastatic breast cancer. Combination cytotoxic therapy is associated with a higher response rate, but toxicities are also increased, and it confers no survival benefit. Chemotherapy is used in patients with resistance to endocrine therapy or ER/PR-negative disease and a moderate or high disease burden.

Discover highlights from ASCO 2021 on the management of metastatic breast cancer here.

Learn more about the treatment and management of metastatic breast cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.